North Carolina Coalition Initiative
NIDA Study Finds Sustained Buprenorphine/Naloxone Effective at Treating Painkiller Abuse
People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in yesterday’s Archives of General Psychiatry and conducted by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The study, which was the first randomized large scale clinical trial using a medication for the treatment of prescription opioid abuse, also showed that the addition of intensive opioid dependence counseling provided no added benefit. For the full article click here.
FDA & NIH announce joint study on tobacco use and risk perceptions
The U.S. Food and Drug Administration and the National Institutes of Health today announced a joint, large-scale, national study of tobacco users to monitor and assess the behavioral and health impacts of new government tobacco regulations.
The initiative, called the Tobacco Control Act National Longitudinal Study of Tobacco Users, is the first large-scale NIH/FDA collaboration on tobacco regulatory research since Congress granted FDA the authority to regulate tobacco products in the Family Smoking Prevention and Tobacco Control Act of 2009. For the full story, visit NIDA's website.
NIH to fund development of K-12 neuroscience education programs
Eight investigators across the United States will receive funding over the next five years to develop innovative neuroscience education programs for K-12 students and their teachers. Activities described within some proposals include using touch tablet technology to teach neurobiology, and the creation of a 1,400-square-foot interactive learning center. These grants are funded by the NIH Blueprint for Neuroscience Research Science Education Award and the Science Education Partnership Award Program of the National Center for Research Resources (NCRR). The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health and administrator of the grants, made the announcement. For the full story, visit NIDA's website.